Novo Nordisk A/S
NONOF
$49.45
-$0.07-0.14%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.03% | 0.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.03% | 0.46% | |||
| Cost of Revenue | -2.57% | 16.01% | |||
| Gross Profit | 6.85% | -2.66% | |||
| SG&A Expenses | 8.23% | -13.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.70% | -1.02% | |||
| Operating Income | 5.45% | 2.38% | |||
| Income Before Tax | 33.30% | -22.27% | |||
| Income Tax Expenses | 31.69% | -22.28% | |||
| Earnings from Continuing Operations | 33.74% | -22.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.74% | -22.26% | |||
| EBIT | 5.45% | 2.38% | |||
| EBITDA | -0.05% | -0.18% | |||
| EPS Basic | 33.73% | -22.26% | |||
| Normalized Basic EPS | 6.67% | 6.89% | |||
| EPS Diluted | 33.62% | -22.25% | |||
| Normalized Diluted EPS | 6.61% | 6.88% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.00% | |||
| Dividend Per Share | -- | -100.00% | |||
| Payout Ratio | -1.00% | -- | |||